tiprankstipranks
BerGenBio AS (BRRGF)
OTHER OTC:BRRGF

BerGenBio AS (BRRGF) Income Statement

37 Followers

BerGenBio AS Income Statement

Last quarter (Q1 2023), BerGenBio AS's total revenue was kr66.54M, an increase of Infinity% from the same quarter last year. In Q1, BerGenBio AS's net income was kr16.27M. See BerGenBio AS’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
kr 121.88Mkr 209.17Mkr 195.64Mkr 601.00Kkr 8.90Mkr 2.33M
Cost of Revenue
------
Gross Profit
------
Operating Expense
kr 150.66M--kr 261.69Mkr 213.27Mkr 196.87M
Operating Income
kr -150.66M--kr -261.09Mkr -204.37Mkr -194.54M
Net Non Operating Interest Income Expense
kr 6.80M--kr 4.06Mkr 5.09Mkr 2.79M
Other Income Expense
------
Pretax Income
kr -102.69Mkr 78.69Mkr 81.08Mkr -257.03Mkr -199.28Mkr -191.75M
Tax Provision
kr 8.61Mkr 15.77Mkr 16.91Mkr 0.00kr 0.00kr 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
kr -80.48Mkr 62.87Mkr 64.21Mkr -257.03Mkr -199.28Mkr -191.75M
Basic EPS
kr -1.62--kr -3.43kr -3.39kr -3.54
Diluted EPS
kr -1.62--kr -3.43kr -3.39kr -3.54
Basic Average Shares
kr 177.32M--kr 74.92Mkr 58.77Mkr 54.18M
Diluted Average Shares
kr 177.32M--kr 74.92Mkr 58.77Mkr 54.18M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
kr 1.97M--kr 2.36Mkr 2.09Mkr 1.95M
Total Expenses
kr 150.66M--kr 261.69Mkr 213.27Mkr 196.87M
Net Income From Continuing And Discontinued Operation
kr -111.35Mkr 62.87Mkr 64.21Mkr -257.03Mkr -199.28Mkr -191.75M
Normalized Income
kr -143.87M--kr -257.03Mkr -199.28Mkr -191.75M
Interest Expense
kr 22.00Mkr -22.58Mkr -19.68Mkr 32.00Kkr 109.00Kkr 47.00K
EBIT
kr -97.10Mkr 78.69Mkr 81.08Mkr -257.00Mkr -199.17Mkr -191.70M
EBITDA
kr -84.98Mkr 92.57Mkr 94.84Mkr -256.27Mkr -198.38Mkr -191.50M
Currency in NOK

BerGenBio AS Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis